Search Within

Craig Steven Sauter

Formats
  1. Meeting Abstract (203)
  2. Journal Article (113)
  3. Research Letter (7)
  4. Review (5)
  5. Guidelines (3)
  6. Book Section (2)
  7. Editorial (1)
Groups
  1. Bone Marrow Transplant (334)
  2. Center for Hematologic Malignancies (334)
  3. Department of Medicine (334)
  4. Hematologic Malignancies, Division of (334)
  5. Survivorship Research (233)
  6. CTCR Scholars (204)

More Groups

People
  1. Miguel-Angel Perales (195)
  2. Sergio Giralt (192)
  3. Parastoo Dahi (135)
  4. Sean Devlin (127)
  5. Esperanza Papadopoulos (101)
  6. Juliet Barker (94)

More People

Years
  1. 2024 (1)
  2. 2023 (14)
  3. 2022 (32)
  4. 2021 (36)
  5. 2020 (42)
  6. 2019 (41)

More Years

Publications
  1. Blood (102)
  2. Biology of Blood and Marrow Transplantation (80)
  3. Bone Marrow Transplantation (25)
  4. Transplantation and Cellular Therapy (20)
  5. Blood Advances (18)
  6. Journal of Clinical Oncology (13)

More Publications

Publishers
  1. American Society of Hematology (120)
  2. Elsevier Inc. (106)
  3. Nature Publishing Group (34)
  4. American Society of Clinical Oncology (13)
  5. Wiley Blackwell (10)
  6. Taylor & Francis Group (9)

More Publishers

Results (334)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lifting the mantle: Unveiling new treatment approaches in relapsed or refractory mantle cell lymphoma
    Journal Article

    Mussetti, A.; Kumar, A.; Dahi, P. B.; Perales, M. A.; Sauter, C. S.
    Blood Reviews (2015)

    Fulltext@MSK | Save
  • Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)
    Meeting Abstract

    Koehne, G.; Boulad, F.; Barker, J.; Castro-Malaspina, H.; Curran, K.; Giralt, S.; Hasan, A.; Heller, G.; Hsu, K.; Jakubowski, A.; more...
    Bone Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma
    Journal Article

    Sauter, C. S.; Matasar, M. J.; Meikle, J.; Schoder, H.; Ulaner, G. A.; Migliacci, J. C.; Hilden, P.; Devlin, S. M.; Zelenetz, A. D.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save
  • Double-unit cord blood (CB) transplantation (DCBT) combined with haplo-identical peripheral blood CD34+ cells (HaploCD34+) is associated with enhanced neutrophil recovery, universal haplo rejection, and frequent pre-engraftment syndrome
    Meeting Abstract

    Sanchez, M. E.; Ponce, D. M.; Lauer, E.; Lubin, M.; Barone, J.; Byam, C.; Dahi, P.; Meagher, R.; Castro-Malaspina, H.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Management of cytokine release syndrome (CRS) in patients undergoing chimeric antigen receptor modified (CAR) T-cell therapy following autologous stem cell transplant (ASCT)
    Meeting Abstract

    Hylton, H. M.; Featherstone, C.; Sauter, C.
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Successful salvage of high-risk B-cell non-Hodgkin and Hodgkin lymphoma (NHL/HL) with double-unit cord blood transplantation (DCBT) provides a platform for further optimization
    Meeting Abstract

    Dahi, P.; Sauter, C.; Devlin, S.; Lubin, M.; Ponce, D. M.; Giralt, S.; Koehne, G.; Perales, M. A.; Zelenetz, A. D.; Moskowitz, C. H.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide
    Journal Article

    Welch, M. R.; Sauter, C. S.; Matasar, M. J.; Faivre, G.; Weaver, S. A.; Moskowitz, C. H.; Omuro, A. M.
    Leukemia and Lymphoma (2015)

    Fulltext@MSK | Save
  • R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma
    Journal Article

    Omuro, A.; Correa, D. D.; Deangelis, L. M.; Moskowitz, C. H.; Matasar, M. J.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C. C.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: A non-randomised, open-label, single-centre, phase 2 study
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; Mccall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant
    Journal Article

    Ceberio, I.; Devlin, S. M.; Sauter, C.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S.; Ponce, D. M.; Lechner, L.; Maloy, M. A.; Goldberg, J. D.; more...
    Leukemia and Lymphoma (2015)

    Fulltext@MSK | Save